Hypercalcemia in a patient with autoimmune polyglandular syndrome

  • Svetlana Katsnelson | Svetlana.Katsnelson@sbumed.org Department of Medicine, Stony Brook University Medical Center, Stony Brook, NY, United States.
  • Jessica Cella Department of Medicine; Division of Endocrinology and Metabolism, Stony Brook University Medical Center, Stony Brook, NY, United States.
  • Heesuk Suh Department of Medicine; Division of Nephrology, Stony Brook University Medical Center, Stony Brook, NY, United States.
  • Marina M. Charitou Department of Medicine; Division of Endocrinology and Metabolism, Stony Brook University Medical Center, Stony Brook, NY, United States.

Abstract

Hypercalcemia is a rare condition in patients with autoimmune polyglandular syndrome (APS-1), usually characterized by hypoparathyroidism and hypocalcemia, and it can develop due to simultaneous adrenal insufficiency. We present a case of severe hypercalcemia in a patient with APS-1, found to have adrenal insufficiency secondary to steroid non-compliance.

Downloads

Download data is not yet available.
Published
2012-04-04
Section
Case Reports
Keywords:
hypercalcemia, auto-immune polyglandular syndrome, adrenal insufficiency.
Statistics
Abstract views: 624

PDF: 345
HTML: 73
Share it

PlumX Metrics

PlumX Metrics provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Examples include, when research is mentioned in the news or is tweeted about. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.

How to Cite
Katsnelson, S., Cella, J., Suh, H., & Charitou, M. (2012). Hypercalcemia in a patient with autoimmune polyglandular syndrome. Clinics and Practice, 2(2), e39. https://doi.org/10.4081/cp.2012.e39